Taking a shot at recovery: Why 2021 will be the year of the vaccine and not the virus

Block out short-term noise for better rewards

Over the past 12 months, the US has faced its fair share of uncertainty, juggling the impact of Covid-19, with its social and economic impacts, alongside a contentious presidential election race.

Yet as active managers, our role is to find US gems which should withstand any market condition, regardless of short-term noise.  When looking at the market thematically, Covid-19 has accelerated existing trends facing US businesses, such the evolution of technology and consumption patterns. However, as we move towards recovery, we have seen biggest valuation shift from growth to value stocks in US history, which demonstrates the overall optimism in the market.  While in the short term, US companies are still battling the virus, sentiment is strong, and we have positive expectation...